Skip to main content
Veterinary Medicines

CRYOMAREX RISPENS

Not authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live

Product identification

Medicine name:
CRYOMAREX RISPENS
Cryomarex Rispens, Suspenze a rozpouštědlo pro injekční suspenzi
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
Target species:
  • Chicken (chick, for replacement)
  • Chicken (broiler)
  • Chicken (for reproduction)
  • Chicken (layer hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
    10000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (chick, for replacement)
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (chick, for replacement)
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:
  • 6 ampoules of 2000 doses of frozen suspension and 1 bag of 2.400 ml of diluent
  • 2 ampoules of 2000 doses of frozen suspension and 1 bag of 800 ml of diluent
  • 1 ampoule of 2000 doses of frozen suspension and 1 bag of 400 ml of de diluent
  • 9 ampoules of 1000 doses of frozen suspension and 1 bag of 1.800 ml of diluent
  • 7 ampoules of 1000 doses of frozen suspension and 1 bag of 1.400 ml of diluent
  • 6 ampoules of 1000 doses of frozen suspension and 1 bag of 1.200 ml of diluent
  • 3 ampoules of 1000 doses of frozen suspension and 1 bag of 600 ml of diluent
  • 2 ampoules of 1000 doses of frozen suspension and 1 bag of 400 ml of diluent
  • 1 ampoule of 1000 doses of frozen suspension + 1 bag of 200 ml of diluent

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/051/14-C
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0216/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022

Package Leaflet

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."